Dentists claim weight-loss drugs could majorly impact users' saliva glands, helping gum disease to fester in their mouths.

The unnamed 67-year-old man from Israel had been prescribed Semaglutide to treat his type 2 diabetes and also to help him lose weight .

Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer discounted access to competing products. ETFs with high concentration in HIMS may face risks and losses.